|
2025
|
P/S
|
Business consulting and advisory services in the fields of innovation, organizational change, and... |
|
|
P/S
|
Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Phar... |
|
2024
|
P/S
|
Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders... |
|
|
P/S
|
Conducting incentive award programs for Non-Governmental Organization employees to support and pr... |
|
|
P/S
|
Human pharmaceutical preparations. Research services in the field of human pharmaceuticals.
Medic... |
|
|
Invention
|
Emrusolmin for use in treating multiple system atrophy. The disclosure provides methods of stabil... |
|
|
Invention
|
Methods and systems for detecting the progression of a movement disorder. A method for detecting ... |
|
|
P/S
|
Pharmaceutical preparations. |
|
|
P/S
|
Pharmaceutical preparations. |
|
|
P/S
|
Training services for pharmacists in the field of pharmacy; educational services, namely conducti... |
|
|
P/S
|
Medical apparatus for facilitating the inhalation of pharmaceutical preparations; inhalers for th... |
|
|
P/S
|
Educational services, namely, conducting classes and seminars in the field of neurology, cancer, ... |
|
|
Invention
|
Movement disorder detection and assessment. The present disclosure relates to systems and methods... |
|
2023
|
Invention
|
Emptying monitoring system for gastrointestinal tract devices. Disclosed herein are apparatus, sy... |
|
|
P/S
|
Conducting incentive award programs for Non-Governmental Organizations to support and promote hea... |
|
|
P/S
|
Human pharmaceutical preparations. Research services in the field of human pharmaceuticals. |
|
|
P/S
|
Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutic... |
|
|
P/S
|
Human Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, depres... |
|
|
P/S
|
Bulk pharmaceutical chemicals and fine chemicals for use in the manufacture of pharmaceuticals; c... |
|
|
P/S
|
Training services for pharmacists in the field of pharmacy; Educational services, namely, conduct... |
|
2022
|
P/S
|
Downloadable software in the nature of a mobile application for providing an on-line database to ... |
|
|
Invention
|
S1p3 antagonists.
The present invention relates to antagonists of the S1P3 receptor formula (A) ... |
|
|
Invention
|
Retentive devices for gastrointestinal tract.
A device for temporary residence at a predetermine... |
|
|
Invention
|
Retentive devices for gastrointestinal tract. The present disclosure provides with a device (1000... |
|
|
Invention
|
Fixed-dose pharmaceutical compositions. The invention relates to fixed-dose pharmaceutical compos... |
|
2021
|
Invention
|
Devices and methods for gastric retentive drug delivery.
The present disclosure provides with a ... |
|
|
Invention
|
Devices for regio-specific release of carried drug at ileocecal region.
The present disclosure p... |
|
|
Invention
|
Devices for regio-specific release of carried drug at ileocecal region. The present disclosure pr... |
|
|
Invention
|
Devices and methods for gastric retentive drug delivery. The present disclosure provides with a d... |
|
|
Invention
|
Use of rasagiline for the treatment of restless legs syndrome. Disclosed are methods for the trea... |
|
|
Invention
|
Use of rasagiline for the treatment of restless legs syndrome.
Disclosed are methods for the tre... |
|
2020
|
Invention
|
Devices and methods for regio-specific drug release at ileocecal region. The present disclosure p... |
|
|
Invention
|
Rasagiline for the treatment of restless legs syndrome.
Disclosed are methods for the treatment ... |
|
|
Invention
|
S1p3 antagonists. The present invention relates to antagonists of the S1P3 receptor formula (A) a... |
|
2019
|
Invention
|
Medroxyprogesterone acetate injectable compositions and methods of use. The disclosure is directe... |
|
2018
|
Invention
|
Combination of laquinimod and pridopidine for treating neurodegenerative disorders, in particular... |
|
|
Invention
|
New salt and solid state forms of escitalopram. The present disclosure relates to a new salt of e... |
|
|
Invention
|
Injector pen |
|
|
Invention
|
Re-useable injector device for syringe. An injector device includes an injector body that receive... |
|
|
Invention
|
Method and an apparatus for feeding a filament and use of the apparatus for production of a pharm... |
|
|
Invention
|
Additively manufactured controlled release dosage forms. 3D printed functional dosage forms, and ... |
|
|
Invention
|
Additively manufactured functional dosage forms. 3D printed functional dosage forms, and methods ... |
|
|
Invention
|
Use of laquinimod to delay huntington's disease progression.
The subject invention provides meth... |
|
|
Invention
|
Drug repurposing hypothesis generation using clinical drug-drug interaction information.
Embodim... |
|
|
Invention
|
Automatic generation of user and non-user cohorts for the estimation of drug's effect from longit... |
|
|
Invention
|
Treatment of glaucoma using laquinimod.
The subject invention provides a method of treating a su... |
|
|
Invention
|
5-chloro-4-hydroxy-1-methyl-2-oxo-n-phenyl-1,2-dihydroquinoline-3-carboxamide, salts and uses the... |
|
2017
|
Invention
|
Medical injection device packaging. Packaging for an injection device, the packaging including a ... |
|
2016
|
Invention
|
Quinoline derivatives for use in treating leukodystrophy and treatment method.
The present inven... |
|
|
Invention
|
Method of determining the molecular weight distribution of glatiramer acetate using multi-angle l... |
